Association between ideal cardiovascular health and abnormal glucose metabolism in the elderly: evidence based on real-world data
- PMID: 38730349
- PMCID: PMC11084128
- DOI: 10.1186/s12877-023-04632-4
Association between ideal cardiovascular health and abnormal glucose metabolism in the elderly: evidence based on real-world data
Abstract
Background: Limited information is available on the effect of ideal cardiovascular health (CVH) and abnormal glucose metabolism in elderly people. We aimed to analyze the prevalence of CVH behaviors, abnormal glucose metabolism, and their correlation in 65 and older people.
Methods: In this study, randomized cluster sampling, multivariate logistic regression, and mediating effects analysis were used. Recruiting was carried out between January 2020 and December 2020, and 1984 participants aged 65 years or older completed the study.
Results: The prevalence of abnormal glucose metabolism in this group was 26.7% (n = 529), among which the prevalence of impaired fasting glucose (IFG) was 9.5% (male vs. female: 8.7% vs 10.1%, P = 0.338), and the prevalence of type 2 diabetes mellitus (T2DM) was 19.0% (male vs. female: 17.8 vs. 19.8%, P = 0.256). The ideal CVH rate (number of ideal CVH metrics ≥ 5) was only 21.0%. The risk of IFG and T2DM decreased by 23% and 20% with each increase in one ideal CVH metrics, with OR (95%CI) of 0.77(0.65-0.92) and 0.80(0.71-0.90), respectively (P -trend < 0.001). TyG fully mediated the ideal CVH and the incidence of T2DM, and its mediating effect OR (95%CI) was 0.88(0.84-0.91).
Conclusions: Each increase in an ideal CVH measure may effectively reduce the risk of abnormal glucose metabolism by more than 20%.
Keywords: Abnormal glucose metabolism; Cardiovascular health; Elderly.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- DALYs GBD, Collaborators H. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. doi: 10.1016/S0140-6736(18)32335-3. - DOI - PMC - PubMed
-
- Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65–99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2020;162:108078. doi: 10.1016/j.diabres.2020.108078. - DOI - PubMed
-
- Chinese Elderly Type 2 Diabetes P. Treatment of Clinical Guidelines Writing G. Geriatric E. Metabolism Branch of Chinese Geriatric S. Geriatric E. Metabolism Branch of Chinese Geriatric Health Care S. Geriatric Professional Committee of Beijing Medical Award F. National Clinical Medical Research Center for Geriatric D [Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)] Zhonghua Nei Ke Za Zhi. 2022;61(1):12–50. - PubMed
-
- Washirasaksiri C, Srivanichakorn W, Borrisut N, Sitasuwan T, Tinmanee R, Kositamongkol C, Ariyakunaphan P, Auesomwang C, Sayabovorn N, Chaisathaphol T, et al. Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes. Front Pharmacol. 2022;13:950225. doi: 10.3389/fphar.2022.950225. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
